Proteomic differentiation pattern in the U937 cell line

Leukemia Research

Volumn 35, Issue 2, 2011, Pages 226-236

  Minafra, Luigi ^a   Di Cara, Gianluca ^a   Albanese, Nadia Ninfa ^a   Cancemi, Patrizia ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Proteomics differentiation markers; U937 cell line

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE;

AMINO ACID SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN U937; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; METABOLIC REGULATION; MODULATION; ONCOGENE C MYC; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; STRUCTURAL PROTEOMICS;

BLOTTING, WESTERN; CARCINOGENS; CELL DIFFERENTIATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; IMMUNOPHENOTYPING; MONOCYTES; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TETRADECANOYLPHORBOL ACETATE; U937 CELLS;

EID: 78751705461     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.07.040     Document Type: Article

References (42)

1. Sundström C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976, 17:565-577.
2. Harris P., Ralph P. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukoc Biol 1985, 37:407-422.
3. Olsson I.L., Breitman T.R. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3′:5′-monophosphate-inducing agents. Cancer Res 1982, 42:3924-3927.
4. Olsson I., Gullberg U., Ivhed I., Nilsson K. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol. Cancer Res 1983, 43:5862-5867.
5. Stöckbauer P., Malasková V., Soucek J., Chudomel V. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies. Neoplasma 1983, 30:257-272.
6. Caligo M.A., Cipollini G., Petrini M., Valentini P., Bevilacqua G. Down regulation of NM23.H1, NM23.H2 and c-myc genes during differentiation induced by 1,25 dihydroxyvitamin D3. Leuk Res 1996, 20:161-167.
7. Harris P.E., Ralph P., Litcofsky P., Moore M.A. Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937. Cancer Res 1985, 45:9-13.
8. Morrissette N., Gold E., Aderem A. The macrophage-a cell for all seasons. Trends Cell Biol 1999, May (9):199-201.
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
10. Pucci-Minafra I., Cancemi P., Fontana S., Minafra L., Feo S., Becchi M., et al. Expanding the protein catalogue in the proteome reference map of human breast cancer cells. Proteomics 2006, 6:2609-2625.
11. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
12. Marcu K.B., Bossone S.A., Patel A.J. Myc function and regulation. Annu Rev Biochem 1992, 61:809-860.
13. Ezekowitz R.A., Sastry K., Bailly P., Warner A. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J Exp Med 1990, 172:1785-1794.
14. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995, 182:389-400.
15. Tan M.C., Mommaas A.M., Drijfhout J.W., et al. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol 1997, 27:2426-2435.
16. Buentke E., Zargari A., Heffler L.C., Avila-Cariño J., Savolainen J., Scheynius A. Uptake of the yeast Malassezia furfur and its allergenic components by human immature CD1a+ dendritic cells. Clin Exp Allergy 2000, 30:1759-1770.
17. http://david.abcc.ncifcrf.gov/.
18. Nyakern-Meazza M., Narayan K., Schutt C.E., Lindberg U. Tropomyosin and gelsolin cooperate in controlling the microfilament system. J Biol Chem 2002, 277:28774-28779.
19. Wright S.D., Detmers P.A., Aida Y., Adamowski R., Anderson D.C., Chad Z., et al. CD18-deficient cells respond to lipopolysaccharide in vitro. J Immunol 1990, 144:2566-2571.
20. Postel E.H., Berberich S.J., Flint S.J., Ferrone C.A. Human c-Myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science 1993, 261:478-480.
21. Okabe-Kado J., Kasukabe T., Honma Y., Hayashi M., Henzel W.J., Hozumi M. Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase. Biochem Biophys Res Commun 1992, 182:987-994.
22. Wakimoto N., Yokoyama A., Okabe-Kado J., Nagata N., Motoyoshi K., Honma Y. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia. Br J Cancer 1998, 77:2298-2303.
23. Niitsu N., Okabe-Kado J., Nakayama M., Wakimoto N., Sakashita A., Maseki N., et al. Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia. Blood 2000, 96:1080-1086.
24. Rescher U., Gerke V. Annexins-unique membrane binding proteins with diverse functions. J Cell Sci 2004, 117:2631-2639.
25. Fan X., Krahling S., Smith D., Williamson P., Schlegel R.A. Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes. Mol Biol Cell 2004, 15:2863-2872.
26. Mayran N., Parton R.G., Gruenberg J. Annexin II regulates multivesicular endosome biogenesis in the degradation pathway of animal cells. EMBO J 2003, 22:3242-3253.
27. Kim J., Hajjar K.A. Annexin II: a plasminogen-plasminogen activator co-receptor. Front Biosci 2002, 7:341-348.
28. Lim L.H., Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J 2007, 21:968-975.
29. Donato R. Intracellular and extracellular roles of S100proteins. Microsc Res Tech 2003, 6:540-551.
30. Donato R. S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001, 33:637-668.
31. Leclerc E., Fritz G., Vetter S.W., Heizmann C.W. Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta 2009, 1793:993-1007.
32. Semov A., Moreno M.J., Onichtchenko A., Abulrob A., Ball M., Ekiel I., et al. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 2005, 280:20833-20841.
33. Ghebrehiwet B., Peerschke E.I. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol Immunol 2004, 41:173-183.
34. Bohlson S.S., Fraser D.A., Tenner A.J. Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions. Mol Immunol 2007, 44:33-43.
35. Ogden C.A., deCathelineau A., Hoffmann P.R., Bratton D., Ghebrehiwet B., Fadok V.A., et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001, 194:781-795.
36. Arvieux J., Reboul A., Bensa J.C., Colomb M.G. Characterization of the C1q receptor on a human macrophage cell line U937. Biochem J 1984, 218:547-555.
37. Vegh Z., Goyarts E.C., Rozengarten K., Mazumder A., Ghebrehiwet B. Maturation-dependent expression of C1q binding proteins on the cell surface of human monocyte-derived dendritic cells. Int Immunopharmacol 2003, 3:39-51.
38. Edwards M.J. Apoptosis, the heat shock response, hyperthermia, birth defects, disease and cancer. Where are the common links?. Cell Stress Chaperones 1998, 3:213-220.
39. Melnick J., Dul J.L., Argon Y. Sequential interaction of the chaperones BiP and GRP94 with immunoglobulin chains in the endoplasmic reticulum. Nature 1994, 370:373-375.
40. Singh-Jasuja H., Toes R.E., Spee P., Münz C., Hilf N., Schoenberger S.P., et al. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J Exp Med 2000, 191:1965-1974.
41. Radsak M.P., Hilf N., Singh-Jasuja H., Braedel S., Brossart P., Rammensee H.G., et al. The heat shock protein Gp96 binds to human neutrophils and monocytes and stimulates effector functions. Blood 2003, 101:2810-2815.
42. Wang R., Kovalchin J.T., Muhlenkamp P., Chandawarkar R.Y. Exogenous heat shock protein 70 binds macrophage lipid raft microdomain and stimulates phagocytosis, processing, and MHC-II presentation of antigens. Blood 2006, 107:1636-1642.